Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



CHAIN Biotech appoints Dr Andrew Morgan as Chief Scientific Adviser

Andrew has had a distinguished career at Danisco/DuPont, acting as Chief Scientific Officer (2008–2011) for Danisco and Chief Scientist for DuPont Nutrition & Health (2011–2019).  He was appointed a DuPont Fellow in 2016 and played a key role in helping build DuPont’s microbiome platform. 

Read the rest of entry »

TBAT’s Local Business Support during COVID-19

During these uncertain times, it’s important to highlight who local R&D focused and highly innovative businesses can turn to, to receive support to access the additional funds they need.

Read the rest of entry »

Sareum Signs Global Licensing Deal for its FLT3+Aurora Kinase Inhibitor Programme with a China-based Specialty Pharma Company

Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, is pleased to announce that it has entered into an agreement (the “Agreement”) with a China-based specialty pharmaceutical company (the “Licensee).

Read the rest of entry »

Arcinova’s Senior Director of Business Development Europe named 2020 Northern Powerhouse Export Champion

Arcinova, a multi-service Contract Development and Manufacturing Organisation (CDMO) based in Northumberland, England, is delighted to announce that its Senior Director of Business Development Europe, Dr Nathalie Huther, has been named a 2020 Northern Powerhouse Export Champion by the UK Department for International Trade (DIT).

Read the rest of entry »

Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines

IEli Lilly and Company announced on 31 March  an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. The collaboration will study up to four novel preclinical targets identified by Sitryx that could lead to potential new medicines for autoimmune diseases.

Read the rest of entry »

Fieldfisher advises AIM-quoted Synairgen plc on its £14 million fundraising to expedite a COVID-19 clinical trial

European law firm Fieldfisher, has advised AIM-quoted Synairgen plc, a leading drug discovery and development company based in Southampton, on its £14 million fundraising to begin a clinical trial for a potential COVID-19 therapeutic.

Read the rest of entry »

World Tuberculosis day

Evotec is proud to be part of a new global collaboration of philanthropic, non-profit and private sector organizations who will work together to accelerate the development of novel TB treatment regimens for all TB patients.

Read the rest of entry »

Immediate Financial Support for Knowledge-Intensive Companies

OBN & our ITSIG special interest group have today lobbied the Chancellor to accelerate and advance R&D tax credits as a quick and effective mechanism to provide liquidity to knowledge intensive companies in the sector, suffering from the economic implications of the current COVID-19 pandemic.

Read the rest of entry »

RSSL Pharmaceutical training moves online

As concerns around the coronavirus continue to grow, RSSL's top priority is to protect the health and welfare of our tutors, our team and our learners.  It is for this reason that we have made the decision to move all of our March, April and May 2020 training courses online. 
 

Read the rest of entry »

Arecor Extends Multi-Product Collaboration with Clinical Stage Biotech

Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that it has extended its multi-product collaboration with a US-based clinical stage biotechnology company.  Under the collaboration, Arecor will leverage its Arestat™ technology to develop liquid formulations of two proprietary novel products in oncology and a rare genetic orphan condition.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.